BVS vs CL · rev $573.3M vs P/E 34, rev $20.38B
Bioventus Inc (BVS) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
BVS currently screens at market cap $495.1M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the BVS and CL stock pages for the full models.
Not investment advice.